A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis

被引:23
作者
Cadet, E
Capron, D
Perez, AS
Crépin, SN
Arlot, S
Ducroix, JP
Dautréaux, M
Fardellone, P
Leflon, P
Merryweather-Clarke, AT
Livesey, KJ
Pointon, JJ
Rose, P
Harcourt, J
Emery, J
Sueur, JM
Feyt, R
Robson, KJH [1 ]
Rochette, J
机构
[1] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, MRC, Oxford OX3 9DS, England
[2] CHU Amiens, Fac Med, Serv Genet Med, F-80036 Amiens, France
[3] CHU Amiens, Fac Med, Serv Hepatogastroenterol, F-80036 Amiens, France
[4] CHU Amiens, Fac Med, Serv Endocrinol, F-80036 Amiens, France
[5] CHU Amiens, Fac Med, Serv Med Interne, F-80036 Amiens, France
[6] CHU Amiens, Fac Med, Serv Rhumatol, F-80036 Amiens, France
[7] CHU Amiens, Fac Med, Serv Biochim, F-80036 Amiens, France
[8] Univ Jules Verne de Picardie, F-80036 Amiens, France
[9] Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, ICRF,Gen Practice Res Grp, Oxford OX3 7LF, England
[10] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England
[11] Biobanque Picardie, Amiens, France
[12] Caisse Primaire Assurance Malad Somme, Ctr Examens Sante Somme, F-80000 Amiens, France
关键词
chronic fatigue and arthralgia; diabetes; genetic testing; haemochromatosis; serum iron measurements;
D O I
10.1046/j.1365-2796.2003.01094.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine the optimal means of identifying patients with undiagnosed haemochromatosis. Design. Case-control study where cases are defined by the presence of specific clinical diagnoses or symptoms. Setting. Primary care patients were recruited from three Oxfordshire practices and secondary care patients were recruited from those patients attending specialist clinics in Amiens University Hospital. Subjects. A total of 569 patients recruited via hospital clinics and 60 primary care patients (recruited from 4022 consultations) presenting with the following haemochromatosis associated conditions, diabetes, arthralgia/chronic fatigue, osteoporosis or arthropathy were studied. The control group, a total of 991 healthy volunteers, were recruited through a Health Appraisal Centre. Patients and controls were included in the study if they or their family members had not previously been diagnosed with hereditary haemochromatosis. Main outcome measures. Serum ferritin concentration, transferrin saturation (Tsat) and presence of HFE mutations, C282Y and H63D. The check-up in controls consisted of a questionnaire, clinical examination, biochemical tests and screening for the presence of the C282Y and H63D mutations. Results. Patient groups presenting with unstable diabetes or chronic fatigue and arthralgia together with a raised serum ferritin concentration showed an enrichment in the haemochromatosis-associated genotype HH/YY, odds ratio (OR) = 40.1, confidence interval (CI) = 8.0-202.1 and OR = 103, CI = 22.9-469.7, respectively. Conclusion. Patients presenting to hospital clinics with haemochromatosis associated conditions should be screened biochemically for iron overload. Only those with a serum ferritin >300 mug L-1 or Tsat >40% should subsequently go on to be genotyped for HFE mutations. The patients at greatest risk of having undiagnosed haemochromatosis are those presenting with unstable diabetes, or fatigue and/or arthralgia in the absence of any other explanation.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 32 条
  • [1] EASL International Consensus Conference on Haemochromatosis - Part II. Expert document
    Adams, P
    Brissot, P
    Powell, L
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 487 - 496
  • [2] Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors
    Adams, PC
    Kertesz, AE
    McLaren, CE
    Barr, R
    Bamford, A
    Chakrabarti, S
    [J]. HEPATOLOGY, 2000, 31 (05) : 1160 - 1164
  • [3] Population screening for hemochromatosis
    Adams, PC
    [J]. HEPATOLOGY, 1999, 29 (04) : 1324 - 1327
  • [4] Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis
    Beaton, M
    Guyader, D
    Deugnier, Y
    Moirand, R
    Chakrabarti, S
    Adams, P
    [J]. HEPATOLOGY, 2002, 36 (03) : 673 - 678
  • [5] Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
    Beutler, E
    Felitti, VJ
    Koziol, JA
    Ho, NJ
    Gelbart, T
    [J]. LANCET, 2002, 359 (9302) : 211 - 218
  • [6] BOTHWELL TH, 1995, METABOLIC MOL BASES, P2237
  • [7] A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria
    Brissot, P
    Moirand, R
    Jouanolle, AM
    Guyader, D
    Le Gall, JY
    Deugnier, Y
    David, V
    [J]. JOURNAL OF HEPATOLOGY, 1999, 30 (04) : 588 - 593
  • [8] Clinical aspects of hemochromatosis
    Brissot, P
    Guyader, D
    Loréal, O
    Lainé, F
    Guillygomarc'h, A
    Moirand, R
    Deugnier, Y
    [J]. TRANSFUSION SCIENCE, 2000, 23 (03): : 193 - 200
  • [9] Hereditary hemochromatosis - Gene discovery and its implications for population-based screening
    Burke, W
    Thomson, E
    Khoury, MJ
    McDonnell, SM
    Press, N
    Adams, PC
    Barton, JC
    Beutler, E
    Brittenham, G
    Buchanan, A
    Clayton, EW
    Cogswell, ME
    Meslin, EM
    Motulsky, AG
    Powell, LW
    Sigal, E
    Wilfond, BS
    Collins, FS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02): : 172 - 178
  • [10] Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus
    Conte, D
    Manachino, D
    Colli, A
    Guala, A
    Aimo, G
    Andreoletti, M
    Corsetti, M
    Fraquelli, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (05) : 370 - 373